Zhang, S.; Liu, H.; Liu, Y.; Zhang, J.; Li, H.; Liu, W.; Cao, G.; Xv, P.; Zhang, J.; Lv, C.;
et al. miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis. Int. J. Mol. Sci. 2017, 18, 633.
https://doi.org/10.3390/ijms18030633
AMA Style
Zhang S, Liu H, Liu Y, Zhang J, Li H, Liu W, Cao G, Xv P, Zhang J, Lv C,
et al. miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences. 2017; 18(3):633.
https://doi.org/10.3390/ijms18030633
Chicago/Turabian Style
Zhang, Songzi, Huizhu Liu, Yuxia Liu, Jie Zhang, Hongbo Li, Weili Liu, Guohong Cao, Pan Xv, Jinjin Zhang, Changjun Lv,
and et al. 2017. "miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis" International Journal of Molecular Sciences 18, no. 3: 633.
https://doi.org/10.3390/ijms18030633
APA Style
Zhang, S., Liu, H., Liu, Y., Zhang, J., Li, H., Liu, W., Cao, G., Xv, P., Zhang, J., Lv, C., & Song, X.
(2017). miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences, 18(3), 633.
https://doi.org/10.3390/ijms18030633
